Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
3,240,305
-
Share change
-
-87,798
-
Total reported value
-
$275,327
-
Put/Call ratio
-
837%
-
Price per share
-
$0.09
-
Number of holders
-
31
-
Value change
-
-$7,938
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) as of Q2 2023
As of 30 Jun 2023,
SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,240,305 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., Periscope Capital Inc., Linden Advisors LP, Radcliffe Capital Management, L.P., ARISTEIA CAPITAL LLC, Castle Creek Arbitrage, LLC, Kepos Capital LP, SECURITY BENEFIT LIFE INSURANCE CO /KS/, GOLDMAN SACHS GROUP INC, and JANE STREET GROUP, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.